共 50 条
- [41] Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?BIOLOGY-BASEL, 2020, 9 (10): : 1 - 10Jung, Hyun AePark, SehhoonSun, Jong-MuLee, Se-HoonAhn, Jin SeokAhn, Myung-JuPark, Keunchil
- [42] Quantification of EGFR mutations in primary and metastatic tumors in non-small cell lung cancerJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2014, 33Wei, BingYang, KeZhao, JiuzhouChang, YuxiMa, ZihuiDong, BingGuo, YongjunMa, Jie
- [43] Quantification of EGFR mutations in primary and metastatic tumors in non-small cell lung cancerJournal of Experimental & Clinical Cancer Research, 33Bing WeiKe YangJiuzhou ZhaoYuxi ChangZihui MaBing DongYongjun GuoJie Ma
- [44] Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK MutationsCHEST, 2021, 159 (03) : 1256 - 1264Schwalk, Audra J.Ost, David E.Saltijeral, Sahara N.De La Garza, HenrietteCasal, Roberto F.Jimenez, Carlos A.Eapen, Georgie A.Lewis, JeffRinsurongkawong, WareeRinsurongkawong, VadeeratLee, JackElamin, YasirZhang, JianjunRoth, Jack A.Swisher, StephenHeymach, John, VGrosu, Horiana B.
- [45] Mefatinib as first-line treatment of patients with advanced non-small cell lung cancer harboring rare EGFR mutations.JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)Wang, PingliCao, LimingTian, PanwenRen, ShengxiangMiao, LiyunZhou, ChengzhiFan, YunLi, YupingLv, DongqingZhao, XinYang, MeiZhu, ChaonanXu, JuneSong, YongWang, Kai
- [46] Determining the appropriate treatment for different EGFR mutations in non-small cell lung cancer patientsEXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (06) : 565 - 576Scodes, SimonaCappuzzo, Federico
- [47] The impact of rare EGFR mutations on the treatment response of patients with non-small cell lung cancerEXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (03) : 241 - 244Karachaliou, NikiAngel Molina-Vila, MiguelRosell, Rafael
- [48] The Impact of EGFR Mutations. Treatment with ITKs in Non-Small Cell Lung Cancer PatientsJOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2146 - S2146Garcia Manrique, T.Saavedra, O.Palazon Carrion, N.Perez Gago, C.Calvete, J.Carrillo, R.Valdivia Garcia, F. J.Vicente Baz, D.
- [49] ANALYSIS OF THE EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER PATIENTS AFTER EGFR-TKIS TREATMENTRESPIROLOGY, 2010, 15 : 68 - 68Matsuo, MidoriNanae, TomonagaKoichi, IzumikawaHiroyuki, YamaguchiTakaya, IkedaKatsumi, NakatomiYoichi, NakamuraKazuhiro, TsukamotoShigeru, Kohno
- [50] Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutationsJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)Li, FengeDeng, LigangJackson, Kyle R.Talukder, Amjad H.Katailiha, Arjun S.Bradley, Sherille D.Zou, QingweiChen, CaixiaHuo, ChongChiu, YulunStair, MatthewFeng, WeihongBagaev, AleksanderKotlov, NikitaSvekolkin, ViktorAtaullakhanov, RavshanMiheecheva, NataliaFrenkel, FelixWang, YalingZhang, MinyingHawke, DavidHan, LingZhou, ShuoZhang, YanWang, ZhengluDecker, William K.Sonnemann, Heather M.Roszik, JasonForget, Marie-AndreeDavies, Michael A.Bernatchez, ChantaleYee, CassianBassett, RolandHwu, PatrickDu, XuemingLizee, Gregory